Learning and research

User account menu

Join
Log in

Main navigation

Upcoming events
Learning and research
IDDI Workstreams & Task Forces
Membership
Pulmonary hypertension
Support us
About us

User account menu

Join
Log in

Breadcrumb

Home
Learning and Research

Pagination

Previous page
Page 29

Related content

GoDeep Global PH Registry
Pulmonary Circulation
Pulmonary Hypertension Global Patient Survey (PH GPS)
Latest news

Fulltext search

Reset filters

Fulltext search

Publication Types

Pulmonary Circulation
IDDI Workstream or Task Force Learning
PVRI Digital Webinar Series
PVRI Community Calls
PVRI 2025 Rio
PVRI 2024 London
PVRI 2023 DDDS
PVRI 2022 Athens

Subjects

Basic research and pathophysiology
- Cellular and molecular biology
- Extra-pulmonary vascular cell and tissue types
- Genetics/genomics and other Omics
- Immunology and inflammation
- Infections and PVD
- Right ventricle
Diagnostic and assessment methods
- 1MWT, 6MWT, Incremental shuttle walk test
- Biomarkers
- Cardiopulmonary exercise test
- Genetic markers
- Hemodynamic assessments
- Imaging techniques
- Pulmonary function test
Diseases and clinical manifestations
- Group 1: Pulmonary Arterial Hypertension (PAH)
- Group 2: PH associated with left heart disease
- Group 3: PH associated with lung disease and/or hypoxia
- Group 4: PH associated with pulmonary artery obstruction / CTEPH
- Group 5: PH with unclear and/or multifactorial mechanisms
- Paediatric PH
Emerging trends and future research
- Emerging therapies
- Novel clinical trial designs in PH
- Policy and guidelines
- Technological advances
Epidemiology and public health
- Global health and PH
- Incidence, prevalence, and risk factors
- Population studies and public health initiatives
Patient care and advocacy
- Advocacy and quality of life improvement
- Palliative care in PH
- Psychosocial aspects and patient education
- Special circumstances
- Symptom management
Treatment
- Perioperative care
- PH-specific therapies
- Special populations
- Supportive therapy
- Surgical and interventional procedures

3 February 2024

Adding flexibility to PH trials by implementing adaptive designs: overview of opportunities and challenges

Presented at PVRI 2024 Congress by Sofia Villar, University of Cambridge

Members Only

Member content

3 February 2024

The ins and outs of PDGF signaling as a therapeutic paradigm

Presented at PVRI 2024 Congress by Sophie Nadaud, Sorbonne University and INSERM

Members Only

Member content

3 February 2024

"Liquid Biopsies” during the course of PVD

Presented at PVRI 2024 Congress by Corey Ventetuolo, Alpert Medical School, Brown University

Members Only

Member content

3 February 2024

Beyond the clot: CTEPH pathobiology

Presented at PVRI 2024 Congress by Andrea Yu, Duke University School of Medicine

Members Only

Member content

3 February 2024

A primer on drug repositioning and repurposing strategies

Presented at PVRI 2024 Congress by Steven Corsello, Stanford School of Medicine

Members Only

Member content

3 February 2024

From ‘omics to hypothesis - Insights from molecular & spatial phenotyping

Presented at PVRI 2024 Congress by Kerstin Meyer, Wellcome Sanger Institute

Members Only

Member content

3 February 2024

Management and treatment options for low and middle-income countries

Presented at PVRI 2024 Congress by Gil Golden, United Therapeutics Corporation

Members Only

Member content

3 February 2024

Global overview of diagnostics

Presented at PVRI 2024 Congress by Jane Kabwe, National Heart Hospital

Members Only

Member content

3 February 2024

Building high-value health systems: opportunities and challenges

Presented at the PVRI 2024 Congress by Rifat Atun, Harvard University

Members Only

Member content

2 February 2024

Role of TBX4 in neonatal and pediatric developmental lung disease

Presented of PVRI 2024 Congress, by Eric Austin, Monroe Carell Jr. Children's Hospital at Vanderbilt University

PVRI 2024 London

Pagination

First page First

Previous page Previous

…

Page 29

Current page 30

Page 31

Page 32

…

Next page Next

Last page Last

Footer Menu

GET LEARNING
- Attend an event
- Keep up with PVD developments
GET CONNECTED
GET INVOLVED

Footer menu - pages

Accessibility
Code of Conduct
Complaints
Cookies & Privacy Policy
Social Media Policy
Terms & Conditions

The Pulmonary Vascular Research Institute (PVRI) is a charity registered in England & Wales no. 1127115 and a Company Limited by Guarantee no. 05780068. VAT registration no. 488 0247 66. Registered office: 5 Tanner Street, London SE1 3LE. Phone number: + 44 (0) 7934 126930.

Translate this page